Roflumilast + Mao Inhibitors Interaction
Moderateinteraction on record
Description
Co-administration may increase roflumilast systemic exposure and may result in increased adverse reactions. Weigh potential for increased adverse reactions against benefit.
Mechanism
CYP3A4 inhibition
Source: NLP:roflumilast